
Making a difference
We believe in making a difference. And our heritage proves that passion for improving patient outcome, through leading technology and integrated medtech solutions, adds value to both healthcare and investors.
The Share
- Getinge B (STO)
- 15 Jan 2021 17:29
- 23,39 USD (-0,31%)
Are you looking for
Silent period
Getinge applies a silent period of 30 days before quarterly reports.
Report on Getinge COVID-19 commercial paper
Annual Report 2019
The annual report for 2019 was published on March 12, 2020.
Download and read it here.
Capital Markets Day 2018
On November 21 2018 we invited analysts, institutional investors and media representatives to our Capital Markets Day in Gothenburg, Sweden.
A recorded webcast of the Capital Markets Day is available to watch through the link below.
Getinge Medium Term Note Prospect
Only available in Swedish.
Rights Issue 2017
On June 14, 2017, Getinge announced the intention to launch a rights issue to strengthen the group’s balance sheet and provide the group an improved financial position. Due to legal restrictions, the information on this part of Getinge’s website is not accessible to certain persons.